Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma
Authors
Keywords
Ependymoma, Recurrent, Immune, Pediatric
Journal
ACTA NEUROPATHOLOGICA
Volume 127, Issue 5, Pages 731-745
Publisher
Springer Nature
Online
2013-11-16
DOI
10.1007/s00401-013-1212-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Fourteen Gene GBM Prognostic Signature Identifies Association of Immune Response Pathway and Mesenchymal Subtype with High Risk Group
- (2013) Arivazhagan Arimappamagan et al. PLoS One
- A prognostic gene expression signature in infratentorial ependymoma
- (2012) Khalida Wani et al. ACTA NEUROPATHOLOGICA
- Laminin alpha 2 enables glioblastoma stem cell growth
- (2012) Justin D. Lathia et al. ANNALS OF NEUROLOGY
- Copy Number Gain of 1q25 Predicts Poor Progression-Free Survival for Pediatric Intracranial Ependymomas and Enables Patient Risk Stratification: A Prospective European Clinical Trial Cohort Analysis on Behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP)
- (2012) J.-P. Kilday et al. CLINICAL CANCER RESEARCH
- Increased Microglia/Macrophage Gene Expression in a Subset of Adult and Pediatric Astrocytomas
- (2012) Jane R. Engler et al. PLoS One
- Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma
- (2011) Hendrik Witt et al. CANCER CELL
- Neutrophil Degranulation and Immunosuppression in Patients with GBM: Restoration of Cellular Immune Function by Targeting Arginase I
- (2011) T. R. Sippel et al. CLINICAL CANCER RESEARCH
- Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
- (2011) Maryam Fouladi et al. JOURNAL OF CLINICAL ONCOLOGY
- Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties
- (2011) Jennifer C. Rodrigues et al. NEURO-ONCOLOGY
- Phase I Trial of Lapatinib in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
- (2010) Maryam Fouladi et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Staging of Intracranial Ependymoma in Children and Adults
- (2010) Andrey Korshunov et al. JOURNAL OF CLINICAL ONCOLOGY
- Cross-species genomics matches driver mutations and cell compartments to model ependymoma
- (2010) Robert A. Johnson et al. NATURE
- Portrait of Ependymoma Recurrence in Children: Biomarkers of Tumor Progression Identified by Dual-Color Microarray-Based Gene Expression Analysis
- (2010) Matthieu Peyre et al. PLoS One
- Immune Gene and Cell Enrichment Is Associated with a Good Prognosis in Ependymoma
- (2009) A. M. Donson et al. JOURNAL OF IMMUNOLOGY
- Glioblastoma-Derived Mechanisms of Systemic Immunosuppression
- (2009) Allen Waziri NEUROSURGERY CLINICS OF NORTH AMERICA
- Pediatric Phase I and Pharmacokinetic Study of Erlotinib Followed by the Combination of Erlotinib and Temozolomide: A Children's Oncology Group Phase I Consortium Study
- (2008) Regina I. Jakacki et al. JOURNAL OF CLINICAL ONCOLOGY
- Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas
- (2008) Y Komohara et al. JOURNAL OF PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now